Predictive value of MRD in Ph+ ALL treated with imatinib in the EsPhALL study, based on IG/TR and BCR/ABL1 methodologies.
In conclusion, early MRD negativity is highly predictive of favorable outcome. The earlier MRD negativity is achieved, the better the prognosis.
PMID: 29079599 [PubMed - as supplied by publisher]
Source: Haematologica - Category: Hematology Authors: Cazzaniga G, De Lorenzo P, Alten J, Röttgers S, Hancock J, Saha V, Castor A, Madsen HO, Gandemer V, Cavé H, Leoni V, Köhler R, Ferrari GM, Bleckmann K, Pieters R, Van der Velden V, Stary J, Zuna J, Escheric G, Zur Stadt U, Aricò M, Conter V, Schrappe Tags: Haematologica Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Genetics | Gleevec | Hematology | Leukemia | Study